ConductScience.org, home

Paper35129409

Investigational agents for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia: progress in clinical trials.

Burgin DJ and 4 others. Expert Opin Investig Drugs, 2022. Cited by 11 papers, by iCite.

Cite this record

ConductScience Library. Investigational agents for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia: progress in clinical trials. Papers, record 35129409. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35129409

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Investigational agents for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia: progress in clinical trials.
PubMed
Journal
Expert Opin Investig Drugs
PubMed
Year
2022
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
1.16
iCite
Revised in PubMed
2025-05-30
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Burgin DJDylan J
2Liu RRyan
3Hsieh RCRoger C
4Heinzinger LRLauren R
5Otto MMichael

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BacteremiaMajor topic
Methicillin-Resistant Staphylococcus aureusMajor topic
Staphylococcal InfectionsMajor topic
Anti-Bacterial Agents
Clinical Trials as Topic
Humans
Staphylococcus aureus

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
ZIA AI000904Intramural NIH HHSUnited StatesZIAAI000904PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References121

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18067738Antibiotic penetration of and bactericidal activity within endothelial cells.Antimicrob Agents Chemother1994https://conductscience.org/library/papers/8067738PubMed
222571999Impact of vancomycin MIC creep on patients with methicillin-resistant Staphylococcus aureus bacteremia.J Microbiol Immunol Infect2012https://conductscience.org/library/papers/22571999PubMed
312491202Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis.Clin Infect Dis2003https://conductscience.org/library/papers/12491202PubMed
421048011LysGH15, a novel bacteriophage lysin, protects a murine bacteremia model efficiently against lethal methicillin-resistant Staphylococcus aureus infection.J Clin Microbiol2011https://conductscience.org/library/papers/21048011PubMed
515668859Efficacy and safety of weekly dalbavancin therapy for catheter-related bloodstream infection caused by gram-positive pathogens.Clin Infect Dis2005https://conductscience.org/library/papers/15668859PubMed
615898002Inhibition of daptomycin by pulmonary surfactant: in vitro modeling and clinical impact.J Infect Dis2005https://conductscience.org/library/papers/15898002PubMed
728386776Real-World Experience with Oritavancin Therapy in Invasive Gram-Positive Infections.Infect Dis Ther2017https://conductscience.org/library/papers/28386776PubMed
824046298Considerations for higher doses of daptomycin in critically ill patients with methicillin-resistant Staphylococcus aureus bacteremia.Clin Infect Dis2013https://conductscience.org/library/papers/24046298PubMed
927520326Ceftaroline as Salvage Monotherapy for Persistent MRSA Bacteremia.Ann Pharmacother2016https://conductscience.org/library/papers/27520326PubMed
1024884578A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study.BMC Infect Dis2014https://conductscience.org/library/papers/24884578PubMed
116356275Rifampin: mechanisms of action and resistance.Rev Infect Dis1983https://conductscience.org/library/papers/6356275PubMed
1229364906A natural human monoclonal antibody targeting Staphylococcus Protein A protects against Staphylococcus aureus bacteremia.PLoS One2018https://conductscience.org/library/papers/29364906PubMed
1315184410Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia.J Clin Microbiol2004https://conductscience.org/library/papers/15184410PubMed
1430038042Effects of Phage Endolysin SAL200 Combined with Antibiotics on Staphylococcus aureus Infection.Antimicrob Agents Chemother2018https://conductscience.org/library/papers/30038042PubMed
1529408610Efficacy and safety of fosfomycin plus imipenem versus vancomycin for complicated bacteraemia and endocarditis due to methicillin-resistant Staphylococcus aureus: a randomized clinical trial.Clin Microbiol Infect2018https://conductscience.org/library/papers/29408610PubMed
1620065327
Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications.
Clin Microbiol Rev2010https://conductscience.org/library/papers/20065327PubMed
1730455229Role of Rifampin against Staphylococcal Biofilm Infections In Vitro, in Animal Models, and in Orthopedic-Device-Related Infections.Antimicrob Agents Chemother2019https://conductscience.org/library/papers/30455229PubMed
1825048851Efficacy and safety of fosfomycin plus imipenem as rescue therapy for complicated bacteremia and endocarditis due to methicillin-resistant Staphylococcus aureus: a multicenter clinical trial.Clin Infect Dis2014https://conductscience.org/library/papers/25048851PubMed
1929378704Impact of Vancomycin MIC on Clinical Outcomes of Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia Treated with Vancomycin at an Institution with Suppressed MIC Reporting.Antimicrob Agents Chemother2018https://conductscience.org/library/papers/29378704PubMed
208613375A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge.Infect Immun1996https://conductscience.org/library/papers/8613375PubMed

See all 121 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
42346648Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia-Guidelines and Recent Developments.Medicines (Basel)2026https://conductscience.org/library/papers/42346648PubMed
40661138Phage and Endolysin Therapy Against Antibiotics Resistant Bacteria: From Bench to Bedside.MedComm (2020)2025https://conductscience.org/library/papers/40661138PubMed
39421990Resilience Against Resistance: Exploring Cutting-edge Therapies for Methicillin-resistant Staphylococcus aureus (MRSA).Curr Med Chem2025https://conductscience.org/library/papers/39421990PubMed
37101261Therapeutic potential of bacteriophage endolysins for infections caused by Gram-positive bacteria.J Biomed Sci2023https://conductscience.org/library/papers/37101261PubMed
36590413Evaluation of analogs of mutacin 1140 in systemic and cutaneous methicillin-resistant Staphylococcus aureus infection models in mice.Front Microbiol2022https://conductscience.org/library/papers/36590413PubMed
36015090Antibiotics and Carbohydrate-Containing Drugs Targeting Bacterial Cell Envelopes: An Overview.Pharmaceuticals (Basel)2022https://conductscience.org/library/papers/36015090PubMed

Download CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ALB213PubTator's text mininghttps://conductscience.org/library/genes/213NCBI Gene
CTSS1520PubTator's text mininghttps://conductscience.org/library/genes/1520NCBI Gene
GLRX551218PubTator's text mininghttps://conductscience.org/library/genes/51218NCBI Gene
LYZ4069PubTator's text mininghttps://conductscience.org/library/genes/4069NCBI Gene
MED15469PubTator's text mininghttps://conductscience.org/library/genes/5469NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35129409

GET https://conductscience.org/api/papers/v1/35129409/references?page=2